How Your Oncology Practice Can Thrive with MACRA: Get Ready for the Quality Payment Program

Meg Barbor, MPH

October 2017, Vol 7, No 10 - Reimbursement

Washington, DC—By now all oncologists know that the implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) is shifting physician reimbursement from a volume- to a value-based model. To succeed with MACRA, practices must become familiar with how this will affect them and get ready to incorporate the new measures to ensure they get the best level of reimbursement under this program. [ Read More ]

A New Prior Authorization Decision-Support Tool Can Reduce the Costs of Cancer Treatment

Dana Taylor

August 2017, Vol 7, No 8 - Reimbursement

Unless the costs of cancer care are reduced significantly, it is estimated that by 2028, the combination of patients’ health insurance premium costs plus out-of-pocket expenses will be the same as the average US household income. Cancer drug costs are escalating at an even faster rate, at least in part because of accelerated new approvals by the FDA and higher drug unit costs. [ Read More ]

ASCO’s New Patient-Centered Oncology Payment Model

Meg Barbor, MPH

June 2017, Vol 7, No 6 - Reimbursement

Orlando, FL—The American Society of Clinical Oncology (ASCO) has developed a proposal for an Alternative Payment Model that is focused on delivering value in oncology and supporting higher-quality and more affordable cancer care. Dan Zuckerman, MD, Executive Medical Director, St. Luke’s Mountain States Tumor Institute, and Past Chair, ASCO’s Clinical Practice Committee, discussed the details of the new Patient-Centered Oncology Payment model at ASCO’s first Oncology Practice Conference in March 2017. [ Read More ]